| Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies LI Kozlovskaya, AN Piniaeva, GM Ignatyev, IV Gordeychuk, VP Volok, ... Emerging microbes & infections 10 (1), 1790-1806, 2021 | 75 | 2021 |
| Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak L Kozlovskaya, A Piniaeva, G Ignatyev, A Selivanov, A Shishova, ... International Journal of Infectious Diseases 99, 40-46, 2020 | 54 | 2020 |
| Vaccination with oral polio vaccine reduces COVID-19 incidence NV Yagovkina, LM Zheleznov, KA Subbotina, AA Tsaan, LI Kozlovskaya, ... Frontiers in Immunology 13, 907341, 2022 | 21 | 2022 |
| Structural characterization of β‐propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particles DV Bagrov, GS Glukhov, AV Moiseenko, MG Karlova, DS Litvinov, ... Microscopy Research and Technique 85 (2), 562-569, 2022 | 20 | 2022 |
| Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial AA Ishmukhametov, AA Siniugina, NV Yagovkina, VI Kuzubov, ... medRxiv, 2022.02. 08.22270658, 2022 | 8 | 2022 |
| Suppression of injuries caused by a lytic RNA virus (mengovirus) and their uncoupling from viral reproduction by mutual cell/virus disarmament OV Mikitas, YY Ivin, SA Golyshev, NV Povarova, SI Galkina, ... Journal of virology 86 (10), 5574-5583, 2012 | 8 | 2012 |
| Enteroviruses manipulate the unfolded protein response through multifaceted deregulation of the Ire1-Xbp1 pathway A Shishova, I Dyugay, K Fominykh, V Baryshnikova, A Dereventsova, ... Viruses 14 (11), 2486, 2022 | 7 | 2022 |
| Immunogenicity and safety of inactivated Sabin-strain polio vaccine “PoliovacSin”: Clinical trials Phase I and II A Piniaeva, G Ignatyev, L Kozlovskaya, Y Ivin, A Kovpak, A Ivanov, ... Vaccines 9 (6), 565, 2021 | 7 | 2021 |
| Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts IV Gordeychuk, LI Kozlovskaya, AA Siniugina, NV Yagovkina, VI Kuzubov, ... Viruses 15 (9), 1828, 2023 | 6 | 2023 |
| CoviVac vaccination induces production of neutralizing antibodies against Delta and Omicron variants of SARS-CoV-2 L Kozlovskaya, I Gordeychuk, A Piniaeva, A Kovpak, A Shishova, A Lunin, ... MedRxiv, 2022.02. 10.22270781, 2022 | 4 | 2022 |
| Application of human placenta for cleaning normal and immune sera of animals VG Kozlov, YY Ivin, VP Grachev Epidemiologiya i infektsionnye bolezni 20 (5), 48, 2015 | 2 | 2015 |
| The role of the encephalomyocarditis virus type 1 proteins L and 2A in the inhibition of the synthesis of cellular proteins and the accumulation of viral proteins during infection YY Ivin, AA Butusova, EE Gladneva, GY Kolomijtseva, YK Khapchaev, ... Problems of Virology 68 (5), 428-444, 2023 | 1 | 2023 |
| Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography AA Kovpak, AN Piniaeva, OA Gerasimov, IO Tcelykh, MY Ermakova, ... Vaccines 10 (6), 949, 2022 | 1 | 2022 |
| Application of ultrafiltration membranes for purification and concentration of Sabin poliovirus type 1 AA Kovpak, YY Ivin, AN Piniaeva, YK Khapchaev, SV Ozherelkov, ... Journal of microbiology, epidemiology and immunobiology 98 (2), 135-143, 2021 | 1 | 2021 |
| Применение человеческой плаценты для очистки нормальных и иммунных сывороток животных ВГ Козлов, ЮЮ Ивин, ВП Грачев Эпидемиология и инфекционные болезни 20 (5), 48-51, 2015 | 1 | 2015 |
| Comprehensive Elucidation of the Role of L and 2A Security Proteins on Cell Death during EMCV Infection Y Ivin, A Butusova, E Gladneva, A Gmyl, A Ishmukhametov Viruses 16 (2), 280, 2024 | | 2024 |
| Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example. DD Zhdanov, YY Ivin, AN Shishparenok, SV Kraevskiy, SL Kanashenko, ... Biomeditsinskaia Khimiia 69 (5), 253-280, 2023 | | 2023 |
| Method of obtaining purified SARS-CoV-2 antigen for structural and immunological studies in whole-virion vaccines against coronavirus infection AN Zyrina, IO Tselykh, AS Bogdan, A Kovpak, YY Ivin, VE Vasilenko, ... Medical academic journal 22 (2), 183-189, 2022 | | 2022 |
| Human MBNL1 gene is involved in the life cycle of echoviruses and coxsackie A viruses A Kushcheko, P Grobushkin, A Krasota, E Gladneva, Y Ivin, N Kalinina, ... FEBS OPEN BIO 12, 165-165, 2022 | | 2022 |
| Применение ионообменной хроматографии при разработке технологии получения инактивированной вакцины против полиомиелита АН Пиняева, АА Ковпак, ЮЮ Ивин, СХ Санджиева, АА Шишова, ... Эпидемиология и вакцинопрофилактика 21 (5), 107-119, 2022 | | 2022 |
Liubov KozlovskayaFSASI "Chumakov FSC R&D IBP RAS" (Institute of poliomyelitis)Verified email at chumakovs.su
